Month: August 2022

– Enrollment on pace for ongoing pivotal Phase 3 RECOVER trial – – Topline data for RECOVER evaluating brilaroxazine for schizophrenia expected in mid-2023 – – $19.4 Million in Cash as of June 30, 2022 – CUPERTINO, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today reported financial results for the second quarter ended June 30, 2022 and summarized recent business highlights. “This quarter our focus remained on further advancing the clinical development of our lead asset, brilaroxazine, in the ongoing pivotal Phase 3 RECOVER...

Company continues to advance ALRN-6924 as a selective chemoprotective agent for all patients with p53-mutated cancer, with immediate focus on breast cancer clinical trial Extended cash runway expected to support operations through end of 1Q 2024 Presented new data at the Society for Investigational Dermatology 2022 Annual Meeting suggesting ALRN-6924’s potential to protect against chemotherapy-induced alopecia Reported new data from healthy volunteer study demonstrating ALRN-6924-induced cell cycle arrest in hair follicles and suggesting that higher levels of ALRN-6924 may generally prolong cell cycle arrest Strengthened management team with appointment of Susan L. Drexler as interim Chief Financial Officer (CFO)BOSTON, Aug. 15, 2022 (GLOBE NEWSWIRE) — Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that...

SAN JOSE, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) — Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, announced today its financial results for the second quarter ended June 30, 2022. As of June 30, 2022, the Fund’s net assets were approximately $49.8 million, or $7.22 per share, compared with net assets of approximately $87.4 million, or $12.68 per share as of March 31, 2022. As of June 30, 2022, the Fund’s portfolio included public and private securities valued at approximately $49.3 million, or $7.16 per share, which includes approximately $0.06 per share in cash and cash equivalents. Portfolio Summary (as of 6/30/22)Investment Fair Value1, Fair Value per Share1,2Equity/Debt Investments $48.93 million $7.10Cash/Cash...

SAN DIEGO, Aug. 15, 2022 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leading developer of next-generation lithium-ion (“Li-ion”) battery safety and thermal management technologies, today reported results for the second quarter ended June 30, 2022. Second Quarter 2022 and Recent Operational Highlights:With support of its major recycling partner, KULR gained immediate and open access to commercial partners and customers by securing United Parcel Service (“UPS”) shipping certification, which allows for shipment of batteries utilizing the KULR Safe Case products through UPS’ vast shipping network. The permit allows the United States Department of Transportation (“DoT”) compliant Safe Case to be used as a safe and reusable shipping container...

EUGENE, Ore., Aug. 15, 2022 (GLOBE NEWSWIRE) — Arcimoto, Inc.® (NASDAQ: FUV), makers of rightsized, outrageously fun, ultra-efficient electric vehicles for moving people and stuff, today provided a corporate update and announced financial results for the second quarter ended June 30, 2022. Arcimoto will host a stakeholder and analyst webinar today to discuss the company’s results followed by an investor Q&A powered by Say. To view the webcast use the link below: Arcimoto, Inc. Second Quarter 2022 Corporate UpdateDate: Monday, August 15Time: 2:00 p.m. PDT (5:00 p.m. EDT)Webcast: https://us06web.zoom.us/webinar/register/WN_qPl1haqvSJKawxYz_8tKHA Second Quarter 2022 and Recent Company HighlightsProduced 102 new customer vehicles, the highest vehicle production quarter in Arcimoto’s history.Delivered 41 customer vehicles,...

Third Quarter Revenues Increase 32% to $13.6 Million, Management to Host Webcast and Conference Call Today At 5:00 p.m. ET Brooklyn, NY, Aug. 15, 2022 (GLOBE NEWSWIRE) —  – Cemtrex Inc. (NASDAQ: CETX, CETXP), a technology company driving innovation in Internet of Things (IoT), security, machine vision & artificial intelligence, and augmented & virtual reality, has reported its financial and operational results for the third quarter ended June 30, 2022. Key Third Quarter 2022 and Subsequent HighlightsRevenue increased 32% to $13.6 million compared to $10.3 million in Q3’21, marking third straight quarter of increasing revenue. Q3 gross margin up 310 basis points to 43% in Q3’22 from 40% in the prior year quarter and up from 32% in Q2’ 22. Net Income was a $983,491 loss for the third quarter FY 22, compared to a...

– On Track for Updates on pheEDIT and juMPStart Programs by End of 2022 – – Prioritized Pipeline, Shifting Resources to HMI-103 PKU Gene Editing Trial in Adults While Pausing Enrollment in HMI-102 PKU Gene Therapy Trial Also in Adults – – Received Clearance from Health Canada for juMPStart Trial of Investigational HMI-203 Gene Therapy for Hunter Syndrome and U.S. FDA Orphan Drug Designation – – Announced Optimized MLD Gene Therapy Development Candidate with Plans to Seek a Partner for Program – – Finished Second Quarter 2022 with Strong Cash Position and Extended Runway with Pipeline Prioritization – BEDFORD, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today financial results for the second quarter...

MINNEAPOLIS, Aug. 15, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the quarter ended June 30, 2022. Management is hosting an earnings conference call today at 4:30 p.m. ET. The second quarter was marked by meaningful progress. Q2 and Recent Highlights:First Patient Enrolled in its Aspire Trial. Received approval from the Australian Human Research Ethics Committee (HREC) to expand the company’s global clinical trial to Australia. Closed on the acquisition of Cancer Prevention Pharmaceuticals, Inc. (CPP). Hosted a virtual R&D Day on the company’s investigational drug, ivospemin (SBP-101), as a polyamine metabolism...

Revenue of $51.1 million, up 38%Gross profit of $15.3 million, up 91%Gross margin of 30%, up 840 bps LOS ANGELES, Aug. 15, 2022 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (NASDAQ:EGLX; TSX:EGLX), an integrated gaming entertainment company, today announced financial results for the three and six months ended June 30, 2022. “During the first half of 2022, we delivered our strongest half-year results to date, led by accelerated revenue growth and substantial gross margin expansion. Q2 2022 was strong, with gross profit up 91% versus Q2 2021, driven by more subscription revenue and higher direct sales with repeat and new customers,” commented Adrian Montgomery, CEO of Enthusiast Gaming. “These results were made possible by the commitment and dedication of our over 250 global staff that...

FOR IMMEDIATE RELEASE           NEWSAugust 15, 2022 NYSE: NGS   Natural Gas Services Group, Inc. Reports Second Quarter 2022 Financial and Operating Results Second Quarter 2022 HighlightsRental revenue of $18.1 million, an increase of 16% when compared to the second quarter of 2021 and 6% when compared to the first quarter of 2022. Net loss of $70,000 ($0.01 loss per basic and diluted share) an increase of $1,848,000 when compared to the second quarter of 2021 while a decrease in income of $407,000 when compared to the first quarter of 2022. Adjusted EBITDA of $6.7 million an increase of 49% when compared to the second quarter of 2021 and a 2% decrease when compared to the first quarter of 2022. Please see Non-GAAP Financial Measures – Adjusted EBITDA, below.Midland, Texas, Aug. 15, 2022 (GLOBE NEWSWIRE) —...